Related Experiment Videos

[Progressive multifocal leukoencephalopathy in acquired immunodeficiency syndrome]

A Clavo Sánchez1, D García-Gil, S Sasián Martínez

  • 1Unidad de Enfermedades Infecciosas, Hospital Universitario Puerta del Mar, Cádiz.

Revista Clinica Espanola
|January 1, 1994
PubMed

Insights

Progressive multifocal leukoencephalopathy (PML) is a rare opportunistic infection in HIV-infected individuals, often indicating AIDS. Early diagnosis via imaging and biopsy, alongside antiretroviral therapy, may improve patient outcomes.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Immunology

Context:

  • Progressive multifocal leukoencephalopathy (PML) is a rare opportunistic infection in HIV-infected individuals.
  • PML represented 3.1% of AIDS cases in this cohort.
  • In most cases, PML served as the initial diagnostic marker for AIDS.

Purpose:

  • To characterize the clinical presentation, diagnostic findings, and outcomes of PML in HIV-infected patients.
  • To evaluate the role of antiretroviral therapy in managing PML in this population.

Summary:

  • Seven cases of PML in HIV-infected individuals were analyzed.
  • The most common symptom was a slowly progressing focal neurological deficit.
  • Diagnostic imaging (CT/NMR) showed white matter lesions without contrast enhancement or mass effect.
  • Cerebral biopsy confirmed the diagnosis.
  • Low T4 lymphocyte counts (median 51 cells/mm³) were observed.
  • Four patients died within 20-90 days.
  • Three patients receiving antiretrovirals showed apparent stabilization of the disease.

Impact:

  • PML can be an initial diagnostic indicator for AIDS.
  • Clinical and imaging findings should raise suspicion for PML.
  • Cerebral biopsy is crucial for definitive diagnosis due to often insufficient clinicoradiological data.
  • Antiretroviral therapy may positively influence the course of PML.

Related Concept Videos